AQN vs MGEE

The deterministic health scores indicate significant concerns, with a Piotroski F-Score of 4/9 signaling borderline financial stability and no available Altman Z-Score limiting distress risk assessment. Despite a recent 1Y price surge of +47.5%, the stock trades at a steep valuation (P/E 91.14 vs sector avg 19.73) while reporting a negative profit margin (-1.11%) and an unsustainable dividend payout ratio (371.43%). However, strong operating metrics like 25.07% operating margin, improving EPS trends (+12.5% YoY), and a 4.06% dividend yield provide some support. The lack of insider activity and mixed analyst sentiment (hold) further justify a cautious stance.

MGEE presents a dichotomy between superior operational efficiency and poor valuation metrics. While the Piotroski F-Score of 4/9 indicates stable financial health and the company boasts profit margins and ROE significantly above sector averages, the stock is trading at a substantial premium to its Graham Number ($54.65) and Intrinsic Value ($54.50). The technical trend is currently bearish (0/100), and a consistent history of missing earnings estimates suggests limited near-term catalysts for price appreciation despite a conservative debt profile.